126 related articles for article (PubMed ID: 36908197)
21. Diagnostic potential of Type VII Collagen during oral carcinogenesis.
Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S
J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793
[TBL] [Abstract][Full Text] [Related]
22. Can dual staining with p16 and Ki67 be biomarkers of epithelial dysplasia in oral lesions?
Bharti A; Qayoom S; Jaiswal R; Agarwal P; Singh RK; Agarwal SP; Bhalla S; Makker A; Goel MM
J Cancer Res Ther; 2022; 18(4):1003-1008. PubMed ID: 36149153
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
24. Expression of Epsin3 and its interaction with Notch signalling in oral epithelial dysplasia and oral squamous cell carcinoma.
Ahmed H; Paterson I; Aziz SA; Cremona O; Robinson M; Carrozzo M; Valentine RA
J Oral Pathol Med; 2023 Sep; 52(8):710-717. PubMed ID: 37339783
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma.
Qian L; Qian B; Xu J; Yang J; Wu G; Zhao Y; Liu Q; Yuan Z; Fan Y; Li H
BMC Oral Health; 2023 Apr; 23(1):200. PubMed ID: 37013557
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
28. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma.
Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207
[TBL] [Abstract][Full Text] [Related]
29. Expression of epithelial glycoprotein (EGP40) in oral epithelial dysplasia and oral squamous cell carcinoma (OSCC).
Srichinthu KK; Kumar GS; Prasad H; Rajmohan M; Anuthama K; Yoithapprabhunath TR
Indian J Dent Res; 2020; 31(5):738-742. PubMed ID: 33433512
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa.
Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT
Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
32. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
[TBL] [Abstract][Full Text] [Related]
33. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
34. Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights.
Afkhami M; Maghami E; Gernon TJ; Villaflor V; Bell D
Ann Diagn Pathol; 2023 Apr; 63():152104. PubMed ID: 36640643
[TBL] [Abstract][Full Text] [Related]
35. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
37. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
39. Immunoexpression of C4 Binding Protein in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Mashhadiabbas F; Fayazi-Boroujeni M; Alizadeh A; Namdari M; Mirzaei SA
Iran J Immunol; 2021 Jun; 18(2):95-102. PubMed ID: 34190690
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
